藏黄精
Search documents
林芝逾80种特色产品亮相广州引关注
Nan Fang Du Shi Bao· 2025-11-30 10:21
日前,"粤林同心·山海共兴"2025年林芝经济开发区招商引资(广州)推介会在广东省广州市凯旋华美 达酒店举办。 会上,四位来自林芝经开区的招商引资企业代表分享了他们的创业故事。西藏天禾啤酒有限公司董事 长、总经理黄明剑生动分享了企业以匠心工艺融合冰川活水与高原青稞,酿造出口感清冽的"林芝啤 酒";林芝墨脱茶叶有限公司副总经理刘峰岳为现场嘉宾奉上现泡的墨脱茶,以醇厚茶香传递墨脱茶产 业的独特魅力;西藏虔藏健康产业有限公司总经理王超丹介绍了公司在传承藏药基础上,积极探索大健 康产业的创新路径;西藏富氧科技有限公司董事长成明则重点展示了企业如何通过科技手段破解高原供 氧难题,助力实现"高原无忧"生活愿景。 本次活动创新采用"主会场+户外分会场"双会场模式,其中户外分会场别出心裁地设置在城市中心草 坪,毗邻珠江,遥望广州城市地标"小蛮腰"。户外分会场的展销活动吸引了大量广州市民驻足,来自林 芝的10余家企业带来了80多种特色产品,包括被誉为"高原人参"的藏黄精、独具特色的白肉灵芝以及松 茸等林下资源产品。 分会场现场 入夜,南迦巴瓦雪山主题展板亮起灯,与珠江彼岸的广州塔交相辉映,营造出"粤林同框"的独特景观。 本次推 ...
西藏林芝经开区赴广州招商引资 项目签约额逾6亿元
Zhong Guo Xin Wen Wang· 2025-11-27 15:23
Core Viewpoint - The "Yuelin Tongxin · Shanhai Gongxing" 2025 Linzhi Economic Development Zone investment promotion conference was held in Guangzhou, resulting in four investment projects with a total signed amount of 605 million yuan, focusing on clean energy, green industry, and highland特色 agricultural and animal husbandry industries [1] Group 1: Investment and Economic Development - The Linzhi Economic Development Zone is the only economic development zone in Linzhi City, serving as the core platform for local industrial development and investment attraction [1] - The zone is accelerating the construction of a spatial development pattern characterized by "one axis, two cores, and four bases," with a focus on developing clean energy and highland biological industries as the two leading sectors [1] Group 2: Industry Focus - The development strategy includes the collaborative promotion of four supporting industries: green industry, traditional Chinese medicine, modern services, and commercial logistics, forming a "2+4" modern industrial system [1] - The event featured representatives from four enterprises sharing their entrepreneurial stories in Linzhi, highlighting the local business environment [1] Group 3: Exhibition and Community Engagement - The conference utilized an innovative "main venue + outdoor sub-venue" dual venue model, attracting significant public interest with an outdoor exhibition showcasing over 80 unique products from more than 10 enterprises in Linzhi [1] - Featured products included the "highland ginseng" known as Tibetan Huangjing, unique white meat Ganoderma, and Matsutake mushrooms, emphasizing the region's rich natural resources [1]
西藏加快推进医药产业高质量发展
Zhong Guo Jing Ji Wang· 2025-11-26 06:44
西藏自治区药品监督管理局副局长次仁罗布说,2025年,按照产业发展、标准先行的思路,西藏药监局 持续推进《95部颁藏药标准》修订工作,向国家药监局上报第四批"寒水石散"等14个品种质量标准修订 草案,目前共上报80个品种,获批11个品种。顺利完成"第二批藏药标准三年行动计划"中的44个品种标 准研究,已发布"藏黄精"等18个藏药标准,不断完善藏药地方标准体系。 11月25日,西藏自治区人民政府新闻办公室举办发布会,邀请西藏自治区药品监督管理局相关负责人介 绍2025年西藏药品安全及医药产业高质量发展情况。 此外,西藏药监局还持续推进"高效办成一件事",累计办理审批事项9511件,发放电子证照2700余份, 线上行政许可事项办结率达100%。推进藏药"三结合"证据体系下藏药新药研究,全区在研新药品种13 个,发展势头强劲。出台《藏药材产地加工(趁鲜切制)指导意见》,发布第一批9个藏药材产地加工品 种目录及规程,加快藏药材开发利用。藏医器械规范化管理稳步推进,助推"藏医头部热疗仪"等5个藏 医专用医疗器械上市并进入临床使用,填补了藏医器械领域标准和产品的空白,藏医器械产值达1000余 万元,有效推动藏医药传承创新 ...
西藏1600余个首方剂信息录入“中国藏药资源库”
Zhong Guo Xin Wen Wang· 2025-11-25 11:35
Core Points - The Tibet Autonomous Region has successfully entered 1,613 first-class prescription information into the "Chinese Tibetan Medicine Resource Database," laying a solid foundation for the protection of Tibetan medicine resources [1][2] - The Tibet Drug Administration is advancing high-quality development in the industry by revising the "95 Tibetan Medicine Standards" and has submitted quality standard revision drafts for 14 varieties to the National Medical Products Administration [1][2] - A total of 80 varieties have been submitted for approval, with 11 varieties already approved, and 44 varieties of standards research have been completed under the "Second Batch of Tibetan Medicine Standards Three-Year Action Plan" [1][2] - The region is actively promoting the development and utilization of Tibetan medicinal materials, having published the first batch of 9 processing varieties and guidelines [1][2] - The Tibet Drug Administration has also conducted the 2025 Tibetan Medicine Practitioner Qualification Examination, with 1,331 participants, receiving widespread recognition [1][2] - The development of the second phase of the smart drug supervision platform has been completed, enhancing the level of drug regulation and achieving seamless integration with national and regional public service systems [2] - The administration has developed technical standards for Tibetan medical devices, leading to the clinical use of five specialized medical devices, which have received positive feedback from Tibetan medical institutions and patients [2]